🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, open-label study of Serplulimab plus chemotherapy (Ca...
Status
Active Not Recruiting
Location
Alabama Oncology
Start Date
2022-11-18
Trial ID
NCT05468489
This phase II trial studies the effects of temozolomide and atezolizumab as...
Status
Recruiting
Location
University of Illinois Cancer Center
Start Date
2022-01-26
Trial ID
NCT04919382
Treatments Being Tested
This global, multicenter, open-label study will evaluate the safety and tol...
Status
Completed
Location
HonorHealth Research Institute - Bisgrove
Start Date
2014-08-18
Trial ID
NCT02174172
Treatments Being Tested
This phase II trial studies the effect of atezolizumab and bevacizumab befo...
Status
Active Not Recruiting
Location
Houston Methodist Hospital
Start Date
2021-02-10
Trial ID
NCT04721132
Treatments Being Tested
This phase II trial studies how well atezolizumab, cobimetinib, and eribuli...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2017-08-11
Trial ID
NCT03202316
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of RP2 in co...
Status
Recruiting
Location
Beverly Hills Cancer Center
Start Date
2024-08-01
Trial ID
NCT05733598
Treatments Being Tested
This phase I pilot trial studies how well atezolizumab, pemetrexed disodium...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2018-07-16
Trial ID
NCT03228537
This research study is studying a combination of two drugs that change the ...
Status
Active Not Recruiting
Location
Dana Farber Cancer Institute
Start Date
2020-08-06
Trial ID
NCT04356729
Treatments Being Tested
This is a single arm phase II trial to (1) evaluate safety and toxicity pro...
Status
Unknown
Location
MUHC
Start Date
2018-05-01
Trial ID
NCT03620435
Treatments Being Tested
This study will evaluate the safety, tolerability, and pharmacokinetics of ...
Status
Completed
Location
HonorHealth Research Institute - Bisgrove
Start Date
2015-07-28
Trial ID
NCT02471846
Treatments Being Tested